Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer
Maarten Vermaas(Association of British Orchestras), Johannes H.W. de Wilt(Radboud University Nijmegen), Floris Ferenschild(Erasmus MC Cancer Institute), Theo Wiggers(University Medical Center Groningen), Alexander M.M. Eggermont(University Medical Center Utrecht), Andreas Marinelli(Medisch Centrum Haaglanden), Joost J. Nuyttens(Erasmus MC Cancer Institute), Wim J. Kirkels(Erasmus MC), Cornelis Verhoef(Erasmus MC Cancer Institute)
Cited by 140
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k